🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Pioglitazone and Exenatide

Found 19 matching trials

Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus

PHASE3

This study will compare the efficacy and safety of exenatide versus placebo...

Status

Completed

Location

Research Site

Start Date

2008-10

Trial ID

NCT00765817

Treatments Being Tested

placebo exenatide

Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh

PHASE4

The study titled "Efficacy and Safety of Omarigliptin, A Weekly Dipeptidyl ...

Status

Unknown

Location

BIRDEM General Hospital

Start Date

2024-09

Trial ID

NCT06449235

Treatments Being Tested

Omarigliptin Sulphonylureas Metformin Other DPP4-i Thiazolidinediones Alpha-Glucosidase Inhibitor Glucagon-Like Peptide-1 Receptor Agonists (GLP1RA)SGLT2 inhibitors

Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study

N/A

To perform an observational analysis to emulate a target trial (i.e., a hyp...

Status

Active Not Recruiting

Location

Brigham and Women's Hospital

Start Date

2021-08-01

Trial ID

NCT05220917

Treatments Being Tested

SGLT2 inhibitor DPP-4 inhibitor GLP-1RA 2nd generation SU

Effect of Pioglitazone and Exenatide on Body Weight and Beta Cell Function

PHASE4

Pioglitazone, a drug used in treatment of type 2 diabetes has been shown to...

Status

Completed

Location

Barter Research Center, ALM VA Hospital

Start Date

2007-06

Trial ID

NCT00845182

Treatments Being Tested

Pioglitazone Exenatide Pioglitazone and Exenatide

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period

PHASE3

Primary Objective: To demonstrate the superiority of the insulin glargine/...

Status

Completed

Location

Investigational Site Number 8400064

Start Date

2016-07-06

Trial ID

NCT02787551

Treatments Being Tested

Insulin glargine/lixisenatide fixed ratio combination liraglutide exenatide exenatide extended-release albiglutide dulaglutide Background therapy: Oral Anti-diabetic Drug (Metformin, Pioglitazone, SGLT2 inhibitor)

A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)

PHASE3

This study will compare the benefits of exenatide once weekly treatment to ...

Status

Completed

Location

Research Site

Start Date

2008-01

Trial ID

NCT00637273

Treatments Being Tested

exenatide once weekly sitagliptin pioglitazone placebo tablet placebo once weekly

Durability of Combination Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy in New Onset T2DM

PHASE4

Type 2 diabetes is a systemic metabolic disease with significant morbidity ...

Status

Completed

Location

Texas Diabetes Institute

Start Date

2009-01

Trial ID

NCT01107717

Treatments Being Tested

metformin\pioglitazone\exenatide metformin, glyburide and glargine

Incretin-based Drugs and Acute Pancreatitis

N/A

The purpose of this study is to determine whether incretin-based drugs (use...

Status

Completed

Location

Lady Davis Institute for Medical Research, Jewish General Hospital

Start Date

2014-03

Trial ID

NCT02476760

Treatments Being Tested

DPP-4 inhibitors GLP-1 analogs Insulins Biguanides Sulfonylureas Thiazolidinediones Alpha-glucosidase inhibitors Meglitinides

A Study for Comparison of Canagliflozin Versus Alternative Antihyperglycemic Treatments on Risk of Heart Failure Hospitalization and Amputation for Participants With Type 2 Diabetes Mellitus and the Subpopulation With Established Cardiovascular Disease

N/A

The primary purpose of study is to estimate the incidence and comparative e...

Status

Completed

Location

Janssen Investigative Site

Start Date

2018-02-22

Trial ID

NCT03492580

Treatments Being Tested

Canagliflozin Empagliflozin Dapagliflozin Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Glucagon-like Peptide-1 (GLP-1) Agonist Anti-hyperglycemic Agents (AHA)Thiazolidinediones (TZD)Sulfonylureas (SU)Insulin

Use of Continuous Glucose Monitoring Combined With Ambulatory Glucose Profiles to Characterize Glycemic Control

N/A

Obtain Continuous Glucose Monitoring (CGM) data from individuals taking exe...

Status

Completed

Location

Joslin Diabetes Center

Start Date

2008-04

Trial ID

NCT00806520

Previous Next